NVO

Q: What is the price of Novo Nordisk (NVO) today?

The price of Novo Nordisk (NVO) today is US$ 56,93, with a variation of -51.26% compared to the last year. The price of Novo Nordisk (NVO) started the year trading around US$ 86,02 and today it is at US$ 56,93. Follow the real-time price chart, the historical price of Novo Nordisk (NVO), and stock data from Ibovespa and international markets.

Q: When does Novo Nordisk (NVO) pay dividends?

Novo Nordisk (NVO) distributed dividends in the last year,in the months of April, August and September totaling US$ 1,69. The Dividend Yield for the last 12 months is 2,83%.

Q: Novo Nordisk (NVO) is it worth it?

Currently, Novo Nordisk (NVO) is priced at US$ 56,93, with a P/E of 16,20%, representing a deviation of 29,85% from its historical average P/E. In the last year, the stock showed a variation of -51.26% in its price and distributed US$ 1,69 in dividends, resulting in a Dividend Yield of 2,83%. The total shareholder return was -51,26%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Novo Nordisk (NVO)?

Investing in stocks of Novo Nordisk (NVO) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Novo Nordisk (NVO) yield today?

The yield of Novo Nordisk (NVO) was 4,71% in the last month, -51,26% in the last year and 67,60% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 1,69 in dividends, um Dividend Yield de 2,83%.If you wanted to buy 100 stocks of Novo Nordisk (NVO) today, the total investment would be US$ 5.693,00, based on the current price of US$ 56,93.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 2.774,77In 5 years: US$ 9.541,47In 10 years: 14.571,80It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Novo Nordisk A/S

Price

US$ 56,93

variation (12m)

-51,26%

p/l

16,20

p/vp

10,21

DIVIDEND YIELD

2,83%

price NVO

BVMF

NVO

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of NVO

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

4,71%

3 months

-16,47%

1 year

-51,26%

2 years

-41,08%

5 years

67,60%

10 years

155,96%

real profitability

profitability minus inflation.

1 month

4,71%

3 months

-16,78%

1 year

-53,40%

2 years

-46,22%

5 years

23,85%

10 years

53,25%

Indicators NVO

check out the fundamentals of Novo Nordisk shares

P/E

16,20

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

5,63

Sector: -4,23 Industry: -4,23

P/BV

10,21

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

2,83%

Sector: - Industry: -

ROA

21,96%

Sector: -63,87% Industry: -63,87%

ROE

62,99%

Sector: -70,87% Industry: -70,87%

ROIC

21,73%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

34,74%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

83,72%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

44,83%

Sector: -41,04% Industry: -41,04%

P/EBITDA

10,58

Sector: -3,65 Industry: -3,65

P/EBIT

11,52

Sector: -3,64 Industry: -3,64

P/ASSET

3,56

Sector: 1,41 Industry: 1,41

BVPS

5,84

Sector: 1,84 Industry: 1,84

EPS

3,68

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,35

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

19,20%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

20,70%

Sector: - Industry: -

FAIR PRICE OF Novo Nordisk ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 56,93

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-61,37%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

NVO indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of NVO with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History NVO

current DY: 2,83%

5-year average DY: 1,39%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	19/09/2025	29/09/2025	0,00380000
Dividends	18/08/2025	26/08/2025	0,58480000
Dividends	31/03/2025	08/04/2025	1,09920000
Dividends	16/08/2024	26/08/2024	0,51260000
Dividends	25/03/2024	02/04/2024	0,66380000
Dividends	21/08/2023	29/08/2023	0,44180000
Dividends	27/03/2023	04/04/2023	0,59435000
Dividends	15/08/2022	23/08/2022	0,29180000
Dividends	28/03/2022	05/04/2022	0,37065000
Dividends	17/08/2021	25/08/2021	0,27855000
Dividends	29/03/2021	07/04/2021	0,47470000
Dividends	17/08/2020	25/08/2020	0,25890000
Dividends	30/03/2020	07/04/2020	0,39130000
Dividends	19/08/2019	27/08/2019	0,22470000
Dividends	25/03/2019	02/04/2019	0,38850000
Dividends	20/08/2018	28/08/2018	0,16375000
Dividends	26/03/2018	03/04/2018	0,28920000
Dividends	21/08/2017	29/08/2017	0,16795000
Dividends	27/03/2017	04/04/2017	0,23970000
Dividends	15/08/2016	23/08/2016	0,16550000
Dividends	22/03/2016	30/03/2016	0,34970000
Dividends	23/03/2015	31/03/2015	0,26645000
Dividends	25/03/2014	02/04/2014	0,30305000
Dividends	25/03/2013	02/04/2013	0,22643000
Dividends	26/03/2012	03/04/2012	0,18319000
Dividends	28/03/2011	05/04/2011	0,13579000
Dividends	29/03/2010	07/04/2010	0,09786000
Dividends	23/03/2009	31/03/2009	0,07816000
Dividends	17/03/2008	25/03/2008	0,06785000
Dividends	12/03/2007	20/03/2007	0,06195000
Dividends	13/03/2006	21/03/2006	0,03459000
Dividends	14/03/2005	22/03/2005	0,03086000
Dividends	19/03/2004	29/03/2004	0,02605000
Dividends	28/03/2003	07/04/2003	0,01882500
Dividends	15/03/2002	25/03/2002	0,01424000
Dividends	23/03/2001	02/04/2001	0,01580000
Dividends	28/03/2000	06/04/2000	0,01245000
Dividends	29/03/1999	06/04/1999	0,01115000
Dividends	31/03/1998	08/04/1998	0,00610000
Dividends	29/04/1997	07/05/1997	0,00570000
Dividends	03/05/1996	14/05/1996	0,00425000
Dividends	28/04/1995	16/05/1995	0,00385000
Dividends	02/05/1994	18/05/1994	0,00265000
Dividends	28/04/1993	13/05/1993	0,00280000
Dividends	04/05/1992	20/05/1992	0,00270000
Dividends	25/04/1991	10/05/1991	0,00300000
Dividends	27/04/1990	15/05/1990	0,00310000

ABOUT THE COMPANY Novo Nordisk

Novo Nordisk A/S

Average user rating I10

5.0 (240 people)

Estados Unidos

94 years

Foundation: 1931

1981

Year of debut on the stock exchange - 44 years

45.000

Employees

Additional Information

The Company Novo Nordisk A/S (Estados Unidos), is listed on NYSE with a market value of $ 265,17 Billions, having a net worth of $ 25,98 Billions.

With a total of 45.000 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 47,11 Billions, which generated a profit in the amount of $ 16,37 Billions.

As for its main indicators, the Company has a P/E ratio of 16,20, a P/BV ratio of 10,21 and in the last 12 months the dividend yield of NVO was at 2,83%.

The Company is traded internationally through the ticker NVO.

Market value

US$ 265,17 Billions

Net worth

US$ 25,98 Billions

US$ 25.984.230.000,00

Assets

US$ 74,54 Billions

US$ 74.544.370.000,00

Total Number of Shares

4,45 Billions

4.447.000.000

Average Daily Trading Volume

US$ 20,44 Milhões

US$ 20.439.756,00

Sector

Health Care

Industry

Biotechnology

NVO

NVO revenue and profits

NVO results

DRAG THE FRAME TO SEE MORE DATA

NVO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of Novo Nordisk (NVO) today?

The price of Novo Nordisk (NVO) today is US$ 56,93, with a variation of -51.26% compared to the last year. The price of Novo Nordisk (NVO) started the year trading around US$ 86,02 and today it is at US$ 56,93. Follow the real-time price chart, the historical price of Novo Nordisk (NVO), and stock data from Ibovespa and international markets.

When does Novo Nordisk (NVO) pay dividends?

Novo Nordisk (NVO) distributed dividends in the last year,in the months of April, August and September totaling US$ 1,69. The Dividend Yield for the last 12 months is 2,83%.

Novo Nordisk (NVO) is it worth it?

Currently, Novo Nordisk (NVO) is priced at US$ 56,93, with a P/E of 16,20%, representing a deviation of 29,85% from its historical average P/E. In the last year, the stock showed a variation of -51.26% in its price and distributed US$ 1,69 in dividends, resulting in a Dividend Yield of 2,83%. The total shareholder return was -51,26%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Novo Nordisk (NVO)?

Investing in stocks of Novo Nordisk (NVO) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Novo Nordisk (NVO) yield today?

The yield of Novo Nordisk (NVO) was 4,71% in the last month, -51,26% in the last year and 67,60% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 1,69 in dividends, um Dividend Yield de 2,83%.

If you wanted to buy 100 stocks of Novo Nordisk (NVO) today, the total investment would be US$ 5.693,00, based on the current price of US$ 56,93.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 2.774,77
In 5 years: US$ 9.541,47
In 10 years: 14.571,80

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NVO

Novo Nordisk A/S

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of NVO

check out the fundamentals of Novo Nordisk shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 2,83%

5-year average DY: 1,39%

type

date with

payment date

value

ABOUT THE COMPANY Novo Nordisk

Novo Nordisk A/S

Estados Unidos

94 years

1981

45.000

Additional Information

PROFIT X PRICE NVO

NVO results

NVO cash flow

evolution of assets - NVO

NVO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions